NDATOPICALLOTION
Approved
Apr 1955
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5
Data completeness
3/8 — Basic
EURAX (crotamiton) by Journey Medical is clinical pharmacology: pruradik lotion has scabicial and antipruritic actions. First approved in 1955.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EURAX (crotamiton) is a topical lotion with scabicial and antipruritic properties approved in 1955 for the treatment of scabies and pruritus. The exact mechanisms of action are not fully characterized, though the drug demonstrates clinical efficacy in reducing parasitic infestation and associated itching. It represents a long-established, well-tolerated option in dermatology.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), indicating a contracting commercial opportunity and likely smaller field team.
Mechanism of Action
CLINICAL PHARMACOLOGY: Pruradik lotion has scabicial and antipruritic actions. The mechanisms of these actions are not known. The pharmacokinetics of crotamiton and its degree of systemic absorption following topical application have not been determined.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (5)
Neuraxial Ultrasound Device Study
Started Dec 2026
100 enrolled
Labor PainCesarean Delivery Regional Anesthesia Induction
Teaching Neuraxial Ultrasonography With a Virtual Reality Simulator of Spine
Started Jun 2023
46 enrolled
Neuraxial Ultrasonography
PENG Block vs FNB + ONB in Patients Undergoing Hip Fracture Surgery With Contraindications to Neuraxial Anesthesia
Started Jan 2022
40 enrolled
Hip FracturesPain, PostoperativeCoagulopathy+1 more
A Study to Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control
Started Apr 2021
95 enrolled
Central Nervous System InfectionsPseudotumor CerebriNeurological Disorder+4 more
The Effect of a Culturally Sensitive Educational Intervention on Acceptance of Neuraxial Anesthesia
Started Feb 2015
200 enrolled
Labor Pain
Worked on EURAX at Journey Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.